Mesenchymal Stem Cell Administration in the Treatment of Coronary Graft Disease in Heart Transplant Patients

NCT02472002 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

SUSPENDED

Status

14

Enrollment

OTHER

Sponsor class

Stopped Contamination of the Pitié-Salpêtrière biotherapy laboratory

Conditions

Coronary Disease
Heart Transplant

Interventions

BIOLOGICAL: Mesenchymal cell therapy

Sponsor

Assistance Publique - Hôpitaux de Paris